These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1321923)

  • 21. The renin-angiotensin system as a target for therapeutic intervention.
    Swales JD
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S1-5. PubMed ID: 7898088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do angiotensin-converting enzyme (ACE) inhibitors enhance the effect of exercise rehabilitation in patients with hypertension and ACE DD and DI genotypes?
    Duzli Y; Grossman E; Gaides M; Segev S; Gal N; Ben-Dov I
    Arch Phys Med Rehabil; 2007 Feb; 88(2):262-4. PubMed ID: 17270528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterisation of the angiotensin converting enzyme-3 (ACE3) gene: a novel mammalian homologue of ACE.
    Rella M; Elliot JL; Revett TJ; Lanfear J; Phelan A; Jackson RM; Turner AJ; Hooper NM
    BMC Genomics; 2007 Jun; 8():194. PubMed ID: 17597519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACE genotype and ACE inhibitor response in kidney disease: a perspective.
    Mayer G
    Am J Kidney Dis; 2002 Aug; 40(2):227-35. PubMed ID: 12148094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide inhibitors and the active site(s) of angiotensin converting enzyme.
    Riordan JF; Chen YN; Kleemann SG; Bünning P
    Biomed Biochim Acta; 1991; 50(4-6):809-14. PubMed ID: 1666286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plant food-derived Angiotensin I converting enzyme inhibitory peptides.
    Guang C; Phillips RD
    J Agric Food Chem; 2009 Jun; 57(12):5113-20. PubMed ID: 19449887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
    Wu CK; Luo JL; Tsai CT; Huang YT; Cheng CL; Lee JK; Lin LY; Lin JW; Hwang JJ; Chiang FT
    Pharmacogenomics J; 2010 Feb; 10(1):46-53. PubMed ID: 19752885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What have we learned from converting enzyme inhibitors on renin-angiotensin system?].
    Waeber B; Nussberger J; Brunner HR
    Rev Prat; 1992 Dec; 42(20):2529-32. PubMed ID: 1338608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and diagnostic significance of serum angiotensin-converting enzyme activity determination].
    Al'tshuler BIu; Roĭtman AP; Dolgov VV
    Klin Lab Diagn; 2001 Jul; (7):9-13. PubMed ID: 11530537
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of ACE inhibitors in preventing myocardial infarction: potential mechanisms and clinical implications.
    Francis GS
    Eur Heart J; 1995 Nov; 16 Suppl K():1-3. PubMed ID: 8869129
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical application of angiotensin converting enzyme inhibitors].
    Gotoh E; Ishii M
    Nihon Rinsho; 1989 Sep; 47(9):2047-51. PubMed ID: 2593277
    [No Abstract]   [Full Text] [Related]  

  • 32. Ace revisited: a new target for structure-based drug design.
    Acharya KR; Sturrock ED; Riordan JF; Ehlers MR
    Nat Rev Drug Discov; 2003 Nov; 2(11):891-902. PubMed ID: 14668810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Monitoring angiotensin-converting enzyme inhibitors].
    Bolla B; Disdier P; Roux F; Renucci JF; Vaisse B; Harle JR; Poggi L; Weiller PJ
    Presse Med; 1994 Mar; 23(10):491. PubMed ID: 8022729
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibitors of angiotensin-converting enzyme for treatment of hypertension.
    Cushman DW; Ondetti MA
    Biochem Pharmacol; 1980 Jul; 29(13):1871-7. PubMed ID: 6249323
    [No Abstract]   [Full Text] [Related]  

  • 35. [Glucocorticoid receptor mechanism of regulation of the activity of angiotensin-converting enzyme and new prospects in the treatment of cardiovascular diseases].
    Golikov PP
    Vestn Ross Akad Med Nauk; 1992; (3):8-12. PubMed ID: 1382764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exposing ACE up the sleeve...
    Chandrashekhar Y; Narula J
    J Nucl Med; 2007 Feb; 48(2):173-4. PubMed ID: 17268010
    [No Abstract]   [Full Text] [Related]  

  • 37. Restenotic process and DD genotype after angiotensin-converting enzyme inhibitor treatment.
    Radke PW; Sigwart U
    Lancet; 2001 Sep; 358(9283):757; author reply 758-9. PubMed ID: 11556341
    [No Abstract]   [Full Text] [Related]  

  • 38. Microbial synthesis of metabolites with antihypertensive activity: aspects of fermentation derived inhibitors of angiotensin-converting enzyme (ACE).
    Manthey A; Reuter G
    J Basic Microbiol; 1989; 29(9):623-39. PubMed ID: 2560484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer's disease.
    Koronyo-Hamaoui M; Shah K; Koronyo Y; Bernstein E; Giani JF; Janjulia T; Black KL; Shi PD; Gonzalez-Villalobos RA; Fuchs S; Shen XZ; Bernstein KE
    Curr Hypertens Rep; 2014 Jul; 16(7):444. PubMed ID: 24792094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme gene polymorphism and antiproteinuric response to renoprotective therapy.
    Gonzalo A; Telleria D; San Millan JL; Ortuño J
    Nephrol Dial Transplant; 1998 Apr; 13(4):1050-1. PubMed ID: 9580535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.